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Lymphocytic choriomeningitis  (LCM) 1 virus  infection  of mice  produces  di- 
verse disease syndromes depending upon the strain of virus, the route and dose 
of infection, and the age and strain of the mouse (1-5). 
Historically,  perhaps  the  most  significant  syndrome  is  the  vertically  transmitted 
(congenital) carrier state in which fetuses of infected mothers are infected in utero and 
exhibit chronic infection throughout their lives (1-5). These mice either do not respond 
immunologically to  viral  antigens  or  give chronic  antibody responses  which  lead  to 
immune complex-mediated glomerulonephritis (6). It was the specific unresponsiveness 
of such mice which led Burnet and Fenner (7) to make the fundamental postulate of the 
existence of a state of immunological tolerance to those antigens present in the fetal or 
neonatal animal during the ontogeny of the immune system. With the formulation of the 
"Clonal Selection Theory" (8), a more precise statement of this form of tolerance could be 
made, viz., that clones of immunocytes reactive to self-antigens were "forbidden" clones 
and were deleted during ontogeny. 
So far as humoral immunity is concerned, this statement is not strictly true,  since 
antibodies to self-antigens can be demonstrated in a variety of models (9), and there are 
anti-viral antibodies produced in the LCM virus carrier state (6) as mentioned above. 
Another important aspect of the immune response to LCM virus infection in adult mice is 
the generation of thymus-derived (T) cells which lyse LCM virus-infected target cells 
with  great  efficiency (10-12).  Such  T  cells seem to be  responsible for recovery from 
primary infection in adult animals (13, 14) and also seem to provoke another interesting 
syndrome in  animals infected  intracerebrally,  a  lethal  acute  central  nervous  system 
disease (15-18)  (LCM) apparently caused by T-cell attack on LCM virus-infected cells in 
the  choroid plexus and  meninges  (19). LCM  virus congenital  carriers  do not  exhibit 
evidence of a  cytotoxic T-cell response  (10, 11,  20-22).  Since  induction  of a  partially 
tolerant carrier state  is not  dependent  on LCM virus antigens  being present  during 
ontogeny, but can be achieved in neonates or in adults with high doses of virus (5), a re- 
evaluation of the possible mechanisms involved is appropriate, particularly in view of 
recent indications of the active suppression by T  cells of responses to many antigens, 
including self-components (23, 24). 
In this report we describe conditions that lead to either continuation or suppression of 
LCM virus-specific cytotoxic T-cell responses upon transfer of responding cells to an in 
vitro system, or to irradiated syngeneic, recipient mice. We also describe investigations 
' Abbreviations used in this paper: Con A, concanavalin A; LCM, lymphocytic choriomeningitis; 
PFU, plaque-forming units;  PI,  post-infection; SPF,  specific pathogen-free; WE3,  Westminster 
(viscerotrophic) strain of LCM virus. 
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into the suppressive effects of congenital carrier cells both in vitro and after transfer into 
normal recipients. 
Materials and Methods 
Mice and Virus Stocks.  Inbred CBA/H mice of both sexes were bred in the John Curtin School 
and used at 6-8 wk of age. They were either from a specific pathogen-free (SPF) colony, or from a 
WE3 LCM virus congenital carrier colony. SPF mice were infected (i.v.) with 0.2 ml of a  10 -4 
dilution of a guinea pig spleen or lung stock of WE3 LCM virus containing 4,000 intracerebral LDso 
units  (25) equivalent to 250 plaque-forming units (PFU).  Virus stocks were stored in small por- 
tions at -70°C, and a fresh portion was used for each immunization. 
In Vitro Secondary Stimulation.  The procedure for stimulation of spleen cells from previously 
infected mice by cocultivation for varying periods with LCM virus-infected, syngeneic peritoneal 
cells has been described in detail elsewhere (26, 27). 
In Vivo Secondary  Stimulation.  1 day before transfer of the splenic responder T cells under 
test, recipients were given 850 rads from a  e°Co source.  On the day of transfer,  recipients were 
infected i.v. with 2.5 × 104 PFU. 12 h later, spleen cells obtained from donor mice were transferred 
i.v. to groups of four irradiated, infected, or uninfected syngeneic recipients at 108 cells per mouse. 
Mice were then kept for various intervals before removal of their spleens for assay of cytotoxic T- 
cell activity against  virus-infected targets.  Spleens generally  yielded 5  ×  105-5  ×  10  B viable 
lymphoid cells. 
Technique  of 51 Cr Release Assay, and Methods  of Expressing Results.  The assay has been 
described before (25). Targets were LCM virus-infected or uninfected, H-2 compatible L929 cells for 
all figures and tables excepting Table V. Assay incubation time was 16-18 h except with concana- 
valin A (Con A) blast cell targets (Table V). Results were expressed as percent specific lysis =  (% 
51Cr release in presence of effectors -  % medium release)  ×  100/% water lysis. Specific lyses on 
infected targets only are shown for all figures and tables excepting Table V. Data presented are 
the means of four replicates. Standard errors of the mean were never greater than -+2% and were 
omitted for clarity. Statistical significance was determined by Student's t test. 
Generation  of Blast Cells  Using  Con A.  Splenic lymphocytes  from  LCM virus  congenital 
carriers and from normal mice were stimulated in culture with a dose of Con A previously shown 
to produce maximal [SH]thymidine incorporation. 2 Thus, 4.0  ×  107 viable cells were cultured in 
large Falcon plastic flasks (Falcon Plastics, Oxnard, Calif.) in medium containing Con A  (Phar- 
macia Fine Chemicals, Uppsala) for 5 days at 37°C. The resulting blast cells were washed and used 
as 5xCr-labeled targets as described for L929 cells, except that they were used at 105 cells per well 
instead of 5  ×  104, the assay was run for only 2 h  at 37°C to avoid problems due to high rate of 
spontaneous  5~Cr release,  and the assay trays were lightly centrifuged  (1,000  rpm for 10 min) 
immediately after mixing target cells and killer cells to ensure rapid contact between them. 
LCM Virus Neutralizating Antiserum.  Spleen cells from CBA/H mice primed 8 wk previously 
with LCM virus were transferred to syngeneic LCM virus carriers (10  s cells per mouse). Recipients 
were bled 5 wk later. Serum was heat inactivated at 56°C for 30 min to destroy any infectious LCM 
virus present.  This serum had a  titer of 1:60 by neutralization of PFU in vitro. 
LCM Virus Plaque Assay.  This is to be described elsewhere  ~ and is similar to the assay used to 
titrate ectromelia virus (26). 
Results 
Kinetics of Virus Production in Relation to Generation of Cytotoxic  T Cells in 
Spleens.  Virus titers in spleen increased rapidly to peak on days 3-5 after virus 
inoculation and slowly fell thereafter (Fig. 1). Spleen cells showed peak primary 
cytotoxic T-cell activity on day 9; activity fell slowly and there was still signifi- 
cant activity (and persistent virus) by day 21 post-infection (PI) (Fig.  1). The 
relative cytolytic activity of day 5 PI, day 9 PI, and day 21 PI populations have 
been confirmed several times (data not shown). 
2 Cole, G. A., and M. B. C. Dunlop. Manuscript in preparation. 
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FIG.  1.  Kinetics of LCM growth (dashed line) and cytotoxic T-cell activity against LCM- 
infected targets (solid line) in CBA/H mice infected i.v. with 250 PFU of WE3 LCM. Vertical 
bars on virus titer points enclose one standard deviation for groups of four mice.  Effec- 
tot:target ratio of cytotoxicity assay was 20:1; standard errors were too small to be shown. 
Spontaneous s'Cr release from infected targets (20.8%) was subtracted from all points. 
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FIG.  2.  Effect of culture of uninfected (--[]--), Day 5 PI (--A--), Day 9 PI (--~---), or Day 
21 PI (--m--) CBA/H spleen cells with infected syngeneic peritoneal cells for 3, 4, 5, or 6 
days before assay on infected L929 targets.  Effector:target ratio was  1:1,  and peritoneal 
stimulator cell:spleen responder cell ratio was 1:10.  Spontaneous 5~Cr release from infected 
L929 targets was 25.2%. 
Kinetics of Cytotoxic  T-CeU Activity in Spleen  Cell Populations Primed at 
Various Intervals with LCM Virus and then Transferred to an In Vitro Sys- 
tem.  Groups of CBA/H mice were infected i.v. with 250 PFU of WE3 LCM virus 
5,  9,  or 21  days before culture of their spleen cells with syngeneic, infected 
peritoneal "stimulator" cells. Cultures were incubated for 3, 4, 5, or 6 days before 
being assayed against infected L929 target cells on the same day (Fig. 2). Spleen 
cells from uninfected control mice did not generate cytolytic activity in culture, 
while day 5 PI cells did show cytolysis of infected targets which increased in 
activity to peak on day 5 (i.e., about that time, 10 days PI, at which these same 
spleen cells would be expected to reach peak effector activity if they remained in 
the intact infected animal). Day 9 PI spleen cells gave greater cytolytic activity 
than day 5  PI cells but continually declined in activity from 3 to 6  days of 1134  MECHANISMS  OF  SUPPRESSION  IN  LCM  INFECTION 
culture. Day 21 PI spleen cells were very potent for the 4 days of culture assayed 
(Fig.  2); this is an expression of the secondary response of memory T cells (26, 
27). Other results  (not shown) indicated that these three primed spleen cell 
populations were less active after culture with uninfected, syngeneic peritoneal 
cells. 4 
In Vivo Transfer or In Vitro Culture of Spleen Cells at Various Intervals PI 
with LCM virus.  Groups of CBA/H mice were infected i.v. with 250 PFU of 
WE3 virus at intervals, their spleen cells were harvested at various times PI, 
and portions of the spleen cell pools were either transferred into irradiated, 
infected, or uninfected syngeneic recipients and left for 4 days, or cultured with 
syngeneic, infected, or uninfected peritoneal cells for 4 days. Recipients' spleens 
and cultures were then assayed for cytotoxic activity (Table I). Day 9 PI primary 
cells retained cytotoxic activity against infected targets both in vivo and in 
vitro. They retained more potency in a deliberately infected environment than 
in an uninfected environment. Day 21 PI memory cells gave potent secondary 
responses both in vivo and in vitro, and a  deliberately infected environment 
again gave more potent responses. It must be borne in mind, however, that virus 
was present in both day 9 PI and day 21 PI spleen cell populations (Fig. 1) so that 
some infected cells would be present, regardless of the environment into which 
they were transferred. This is even more relevant to the day 5 PI cells which 
contained the largest amounts of virus. These cells gave significant cytotoxic T- 
cell activity in vitro with both infected and uninfected stimulators (more with 
the  former), but  in  vivo  their response  was  largely suppressed  in  infected 
recipients, though it appeared in uninfected  recipients. In several further exper- 
iments there was little evidence of  the generation of cytolytic activity from day 5 
PI primary cells after transfer to infected, irradiated recipients 3, 5, 6, or 8 days 
before assay (data not shown). Also, no activity was detected in other organ sites 
such as thymus, peritoneal cavity, blood, or mesenteric lymph node. Hence, this 
prepeak population appeared to be suppressed in the presence of excess virus in 
vivo. 
Suppression by Transfer to Infected, Irradiated Recipients, or Culture with 
Excess Infected Stimulators, and Effect of Prior Treatment with Neutralizing 
Antiserum.  Spleen cells from CBA/H mice infected i.v. with 250 PFU of WE3 
LCM virus 5 days or 9 wk previously were transferred into infected or unin- 
fected, irradiated recipients, or cultured with infected or uninfected stimulator 
cells (at a  high or low stimulator:responder ratio) for 5 days before assay of 
recipients and cultures on the same day for cytotoxic activity against infected 
targets. A number of  day 5 PI or week 9 PI donor mice were given 0.2 ml of LCM 
virus neutralizing antiserum i.v. 30 min before harvesting spleens for transfer 
or culture (Table II). As demonstrated in Table I, day 5 PI (pre-peak) primary 
cells generated little cytotoxic activity in infected, irradiated recipients com- 
pared with uninfected recipients. Moreover, cocultivation of pre-peak primary 
cells with an excess of infected stimulator cells (stimulator:responder ratio of 
1:1) suppressed  generation of cytotoxic activity compared with  the  cultures 
where a  stimulator:responder ratio  of 1:32 was  used.  In  contrast,  pre-peak 
primary cells from donors  given neutralizing antiserum which presumably 
4 Dunlop,  M.  B.  C.,  P.  C.  Doherty,  R.  M.  Zinkernagel,  and R.  V.  Blanden.  Manuscript in 
preparation. MALCOM  B.  C.  DUNLOP  AND  ROBERT  V.  BLANDEN  1135 
TABLE  I 
Suppression of Generation of Cytotoxic Activity of Day 5 PI Spleen Cells by Transfer to 
Irradiated, Heavily Infected Recipients, but not by Culture with Infected Stimulator 
Cells* 
In vivo transfer  In vitro culture 
Status of re- 
Interval between  cipient (in  Percent  Percent 
priming and sacrific-  vivo) or stimu-  specific  E:T ra-  specific 
ing donors  lator cells (in  E:T ratio 
lysis on in-  tio  lysis on in- 
vitro)  fected L929  fected L929 
Nil (uninfected)  Infected  30:1  0.1  4:1  1.3 
10:1  0  1:1  0 
Uninfected  30:1  4.4  4:1  0 
10:1  1.1  1:1  0 
5  days  (pre-peak  pri-  Infected  30:1  7.85  4:1  24.4§ 
mary)  10:1  3.75  1:1  6.3 
Uninfected  30:1  30.2  4:1  12.5 
10:1  28.8  1:1  4.5 
9 days (peak primary)  Infected  30:1  74.5§  4:1  85.8§ 
10:1  71.0§  1:1  55.6§ 
Uninfected  30:1  37.9  4:1  37.5 
10:1  32.1  1:1  9.2 
21 days (memory)  Infected  30:1  61.3§  4:1  82.0§ 
10:1  54.4§  1:1  76.7§ 
Uninfected  30:1  22.3  4-1  5.1 
10:1  14.3  1:1  6.9 
* Procedures for in vivo transfer and in vitro culture given in Materials and Methods. In vivo 
transfer and in vitro culture were for four days. Medium release on infected targets was 23.7% in 
experiment 1 and 20.4% in experiment 2. 
$ Significantly less lysis  (P  <  0.001)  than  with the relevant control of uninfected irradiated 
recipients for same effector:target ratio on infected targets. 
§ Significantly greater lysis (P <  0.001) than with the relevant controls of uninfected irradiated 
recipients or uninfected stimulator cells at same effecter:target ratio. 
reduced the amount of infectious virus, generated significantly greater cytolytic 
activity on in vivo transfer or in vitro culture in infected or uninfected environ- 
ments (Table II). 
Memory  cells  (9  wk  PI)  gave  potent  secondary  responses  in  an  infected 
environment either  in vivo or in vitro at a  stimulator:responder ratio of 1:32 
(Table II). Uninfected environments gave little secondary response. In contrast 
to pre-peak  (5 day PI) primary cells, the administration of neutralizing antise- 
rum to memory cell donors did not improve expression of the secondary response 
in vitro at the high  stimulator:responder  ratio.  However,  memory cells  were 
also  suppressed  in  vitro  in  the  presence  of very  large  numbers  of infected 
stimulator cells  (stimulator:responder ratio of 1:1). 
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TABLE  II 
Suppression of Generation of Cytotoxic Activity of Day 5 PI Spleen Cells by Transfer to 
Irradiated,  Heavily Infected Recipients and by Culture with Excess Infected Stimulator 
Cells, and Abrogation of Suppression  by Injection of Neutralizing  Antiserum 30 rain 
Before Obtaining Day 5 PI Cells* 
In vitro culture  In vitro culture 
In vivo transfer 
Interval be-  Neutraliz.  (S:R::1:32)*  (S:R::I:I)$ 
tween prim-  Status of recipient 
ing and sac-  ing antise-  (in vivo) or stimu-  Percent spe-  Percent spe- 
rum trans-  Percent spe- 
cific  lysis on  cific  lysis  on  rificing  do-  fer  later  cells  (in  vitro)  E:T ratio  E:T ratio  cific  lysis  on 
nors  infected  infected 
infected L929 
L929  L929 
5 days  No  Infected  30:1  4.6§  4:1  32.4  13.5§. *' 
10:1  5.2§  1:1  12.4  4.3§' ii 
Uninfected  30:1  37.6  4:1  42.2  51.3 
10:1  11.5  1:1  19.6  16.1 
5 days  Yes  Infected  30:1  19.2¶  4:1  60.9~ 
ND 
10:1  15.7¶  1:1  20.0 
Uninfected  30:1  45.0¶  4:1  63.0¶ 
ND 
10:I  22.7¶  1:1  20.7 
9 wk  No  Infected  30:1  79.0  4:1  93.3  12.T  k 
10:1  76.8  1:1  82.6  5.3  *t 
Uninfected  30:1  5.2  4:1  11.0  9.7 
10:1  2.9  1:1  1.6  4.0 
9 wk  Yes  Infected  30:1  4:1  87.4 
ND  ND 
10:1  1:1  81.4 
Uninfected  30:1  4:1  16.3 
ND  ND 
10:1  1:1  2.2 
* Procedures for in vivo transfer, in vitro culture, and antiserum injections given in Materials and Methods. In vivo transfer and in 
vitro culture duration was 5 days. Results were the means of triplicates.  SE of mean were usually less than ± 2% and were omitted 
for clarity.  Medium release was 18.9% on infected targets and 17.3% on uninfected  targets. 
$ S:R, peritoneal stimulater cell:spleen  rceponder cell ratio. 
§ Significantly less lysis (P <  0.001) than with the relevant control of uninfected irradiated recipients or uninfected stimulater cells 
for same effector:target ratio on infected targets. 
" Significantly  less lysis (P <  0.001) than with the relevant control of infected stimulator cells with S:R ratio 1:32, and the same 
effector:target ratio on infected targets. 
¶ Significantly  more lysis  (P  <  0.001) than  with the relevant  control  without neutralizing  antiserum  transfer for same effec- 
ter:target ratio on infected targets. 
Congenital Carrier Spleen Cells.  Having determined that both primary and 
secondary  cytotoxic  T-cell  responses  could  be  suppressed  in  the  presence  of 
excess virus or virus-infected cells in vitro or in irradiated recipients,  suppres- 
sive activity present in congenital carrier cell populations was investigated in a 
similar  manner.  CBA/H  mice were infected  i.v.  with 250 PFU of WE3  LCM 
virus for 5 days,  8 days,  or 9 wk before culturing with equal numbers of either 
syngeneic  normal  or carrier cells,  in the  presence  of either uninfected  or in- 
fected,  syngeneic  peritoneal  stimulator  cells.  All  cultures  were  assayed  for 
cytotoxic activity after 5 days (Table III).  Day 5 PI cells generated cytotoxic T- 
cell  activity  in cultures  with normal  spleen  cells,  but were suppressed  when 
cultured with congenital carrier cells. Day 8 PI primary cytotoxic T cells in the 
presence of infected stimulators were also less active when cultured with carrier 
spleen cells than normal spleen cells, but in the presence of uninfected stimula- 
tors, more cytotoxic activity was generated with carrier cells than normal spleen 
cells. Memory cells (week 9 PI) gave strong secondary responses in all cultures MALCOM  B. C. DUNLOP  AND  ROBERT  V. BLANDEN  1137 
TABLE HI 
Suppression of  Generation of  Cytotoxic  Activity  of  Day 5 PI  Spleen Cells  by Cocultivation 
with Syngeneic LCM  Congenital Carrier  Spleen Cells* 
Component spleen popula- 
tions 
Stimulator status 
Percent specific lysis on in- 
fected L929 
E:T ratio 4:1  E:T ratio 1:1 
Day 5 PI +  normal  Infected  53.1  12.0 
Uninfected  47.8  10.6 
Day 5 PI +  Congenital carrier  Infected  19.3,  2.1, 
Uninfected  15.1,  3.4 
Day 8 PI +  normal  Infected  85.1  29.9 
Uninfected  26.9  5.5 
Day 8 PI + Congenital carrier  Infected  55.4*  13.1, 
Uninfected  51.1  11.6 
Week 9 PI +  normal  Infected  83.1  56.8 
Uninfected  0  0 
Week 9 + Congenital carrier  Infected  81.6  71.5 
Uninfected  86.0  69.3 
* 1.25 × 107 of  each component spleen population were cocultivated  with infected  or uninfected 
syngeneic stimulator  cells  for  5  days  before  assay.  Stimulator:responder ratio  was 1:32.  Medium 
release  was 19.6% on infected  targets. 
* Significantly  less  lysis  (P <  0.001)  than with the relevant control  with normal spleen cell 
component population for  same effector:target  ratio  on infected  targets. 
containing either infected stimulators or carrier spleen cells, or both, but did not 
respond in the absence of both. These results indicated that congenital carrier 
spleen cells could act as  infected stimulators,  presumably because of virus- 
induced antigens  on  their  surface membranes  (4,  5).  This  produced either 
induction of secondary responses, when the responding memory cells carried 
little intrinsic infection, or suppression of primary responses, where the re- 
sponding cells still carried a  considerable virus load, or where additional in- 
fected stimulator cells were present. 
Suppression  of  Primary Response In Vivo by Transfer of  LCM Virus Congen- 
ital  Carrier  Spleen  Cells  (Intact  or Lysed)  or  by an Equivalent Dose of Vi- 
rus.  2.5 × 107 LCM congenital carrier spleen cells were transferred to normal, 
syngeneic CBAJH recipients on various days before or after WE3 LCM virus 
infection (250 PFU i.v.) on day 0; recipients' spleens were assayed for cytotoxic 
T-cell activity on infected target cells 7 days later (day +7). Transfer of congeni- 
tal carrier cells from 7 days before infection or as late as 3 days after infection 
significantly depressed the primary cytotoxic T-cell response (Table IV). Gener- 
ally,  suppression was greater the earlier the carrier cells were transferred. 
Suspensions of carrier spleen cells disrupted by water lysis and sonication, but 
containing infections virus, gave a similar degree of suppression to living carrier 
cells (Table IV). Furthermore, a dose of virus (2.5 × 104 PFU) equivalent to the 
virus content of 2.5  ×  107 carrier spleen cells produced a degree of suppression 
similar to that caused by living or lysed carrier cells (Table IV).  It was also 1138  MECHANISMS  OF  SUPPRESSION  IN  LCM  INFECTION 
TABLE  IV 
Suppression  of Primary Cytotoxic T-Cell Response In Vivo by Transfer  of LCM 
Congenital Carrier Spleen Cells, or Lysed Carrier Cells, or an Equivalent Virus Dose* 
Virus (2.5  x  Day of  Nature of spleen cells (or 
102 PFU) 
transfer  virus) transferred 
given on day 0 
Percent specific lysis of infected 
L929 
E:T ratio 30:1  E:T ratio 6:1 
-7  Carrier  Yes  0.95  05 
-3  Carrier  Yes  11.25  10.65 
-2  Carrier  Yes  20.25  6.65 
-  1  Carrier  Yes  10.75  5.25 
-  1  Lysed carrier  Yes  17.35  6.65 
-1  2.5  x  104  PFU of  Yes  11.35  6.15 
virus 
0  Normal  Yes  61.0  41.2 
0  Nil  Yes  62.8  38.5 
0  Carrier  No  25.65' §  10.15 
0  Normal  No  2.55  2.45 
+1  Carrier  Yes  39.85  13.25 
+2  Carrier  Yes  38.15  22.25 
+3  Carrier  Yes  44.65  29.85 
+6  Carrier  Yes  60.8  39.2 
* 2.5  x  107  LCM congenital  carrier  spleen  cells  (intact  or water  lysed  and  sonicated)  or their 
equivalent  LCM virus content  (2.5  x  104 PFU) were transferred  i.v.  at various  intervals  into 
syngeneic CBA/H recipients. Recipients were given 250 PFU intravenously on day 0, and spleens 
were assayed on day  +7.  Medium release was 20.7% on infected targets. 
5 Significantly  less  lysis  (P  <  0.001)  than  with  the  relevant  control  of  normal  spleen  cells 
transferred followed by 250 PFU of WE3-LCM on day 0 for same effector:target ratio on infected 
targets. 
§ Significantly greater lysis (P <  0.001) than with the relevant control of normal spleen cells only 
transferred on day 0 for same effector:target ratio on infected targets. 
possible  to  produce  suppression  by  transfer  of doses  of living  carrier  cells 
ranging from 5.0 x  107 down to as few as 5.0 x  105 given 1 day before infection 
with LCM virus (data not shown). These results suggested that infectious virus 
or virus-induced antigen, rather than an active suppressive process on the part 
of carrier cells, was responsible for suppression. 
Formaldehyde-fixed carrier cells were not suppressive (data not shown) when 
compared with fixed normal cells in the in vitro protocol  shown in Table III. 
Since such fixed cells display virus-induced antigenic patterns that stimulate 
cytotoxic T cells (26), this reinforced the view that infectious virus was the active 
agent of the suppression exerted by carrier cells. 
It could be argued, however, that large numbers of  carrier cells contaminating 
the cytotoxic T-cell population could act as "cold" competitors in the cytotoxicity 
assay,  thus  exerting a  pseudo-suppressive  effect.  This  was tested by  adding 
carrier cells to cytotoxic T cells generated in their absence, immediately before 
mixing with labeled target cells. The number of carrier cells added was the same 
as that which would result if carrier cells added to the responders in the protocol 
shown by Table III survived in the same proportion as responders till the end of 
the 5-day period in vitro. No competitive effect was detectable. 
Susceptibility of Virus-Infected T Cells to T-Cell-Mediated L ysis.  One possi- 
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TABLE  V 
Susceptibility of  CBA /H Con A-Stimulated Congenital Carrier Blast Cells to 
Lysis by Syngeneic LCM Virus-Specific  Cytotoxic T Cells* Generated in a 
Secondary Response 
1139 
Effector spleen cells  E:T ratio 
Percent specific  lysis 
Congenital car-  Normal 
rier  blasts  blasts 
Normal control  20:1  0  0 
10:1  0  0 
5:1  0  0 
2.5:1  1.9  0 
Secondary  20:1  16.7*  5.0 
10:1  11.65  3.5 
5:1  11.1*  3.3 
2.5:1  7.7§  1.6 
* Procedures for in vitro generation of secondary virus-specific T  cells and Con A 
blasts are given in Materials and Methods. Medium release was 17.0% from carrier 
blasts and 21.7% from normal blasts over the 2-h assay. 
$ Significantly greater lysis (P  <  0.001) than with the relevant control of normal 
spleen cells on same target at the same effector:target ratio. 
§ P  <  0.01. 
specific cytotoxic T cells are themselves infected, display virus-induced antigen 
patterns complementary for their own antigen-receptors, and thus either com- 
mit suicide or kill each other (29-31). To test formally whether LCM  virus- 
infected T cells are susceptible to T-cell-mediated lysis, spleen cells from LCM 
virus congenital carrier or from normal mice were stimulated in vitro with the 
T-cell mitogen Con A (32) for 5 days and then used as labeled target cells, either 
infected or uninfected, respectively. LCM-infected Con A blasts were signifi- 
cantly lysed by syngeneic, LCM virus-specific cytotoxic T cells generated in a 
secondary response in vitro (Table V). 
Discussion 
The  evidence presented here shows  that  T-cell populations  committed to 
either a primary or secondary  response to LCM virus infection can be suppressed 
by a variety of experimental protocols which have one common feature: a high 
level of LCM virus, or infected cells, present in the environment of the respond- 
ing T cells. 
After inoculation of 250  PFC  of WE3  LCM  virus i.v.,  titers in the spleen 
increased for 5 days and then slowly declined. The cytotoxic T-cell response in 
the spleen, measured against virus-infected,  H-2 compatible targets, was detect- 
able by day 5 PI, reached a peak on day 9 PI, and then slowly subsided. Spleen 
cells taken from mice before or at the peak of the response could continue the 
primary response either in vitro or in vivo in irradiated, syngeneic recipients, 
provided  that  correct  conditions  were  provided.  For  day  5  PI  cells,  which 
themselves contained peak virus titers, it was essential not to add further virus 
to the system in vivo.  Thus, if infected, irradiated, syngeneic recipients were 
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maintenance  then uninfected  recipients of the primary response in day 9 PI cells 
and gave stronger induction of secondary responses in cells taken 21 days or 
longer after primary infection. In both of these latter cell populations, intrinsic 
virus levels would be 5-20-fold lower than in day 5 PI cells (Fig.  1). In vitro, 
maintenance of the  primary response in day 5  PI cells was possible in the 
presence of low numbers of additional syngeneic, peritoneal, infected stimulator 
cells (e.g., stimulator:responder ratio of 1:32, see Tables I and II), but with high 
numbers of infected stimulators (e.g., 1:1, see Table II) the response was again 
suppressed. This was not simply due to large numbers of macrophages in the 
system (33), since uninfected peritoneal cells did not suppress.  Furthermore, 
injection of LCM virus-neutralizing antiserum into 5-day PI spleen donors 30 
min before removal and processing of spleens significantly improved the subse- 
quent response in vitro, presumably by reducing the extent of spread of infection 
within the responding spleen cell population.  Taken together, these results 
suggest that too  much virus or  too  many infected cells were in  some way 
responsible for the observed suppression of the primary response. 
Spleen cells from congenital carriers were also examined for their capacity to 
suppress  syngeneic, primary cytotoxic T-cell responses in vitro  and  in vivo. 
When added to an equal number of day 5 PI cells, carrier spleen cells signifi- 
cantly suppressed the continuation of the primary response in vitro,  in the 
presence of either infected or uninfected peritoneal stimulator cells. In the same 
protocol, the response of  day 8 PI cells was suppressed by carrier cells only in the 
presence of infected peritoneal cells, and there was no suppression of secondary 
responses (week 9 PI cells, see Table III). In fact, congenital carrier spleen cells 
actually stimulated responses in both day 8 PI cells and memory cells in the 
presence of uninfected peritoneal stimulator cells, thus indicating that they 
were displaying virus-induced antigenic patterns. 
Virus-induced, cell surface antigens alone, however, did not seem to be the 
suppressive agent of carrier cells, since day 5 PIT cells continued their response 
in vitro in the presence of an equal number of formaldehyde-fixed  carrier cells 
that  display  such  antigens  (26). Another potential  mechanism of action  of 
carrier cells in this type of protocol could be at the level of cytotoxic assay, i.e., 
pseudosuppression of the response by acting as cold competitors for the lysis of 
labeled targets. To do this, carrier cells would need to persist throughout the 
period of cocultivation in vitro, thus contaminating the cytotoxic T-cell popula- 
tion  generated. This  idea was tested by mixing carrier cells with an equal 
number of spleen cells taken from the peak (10 days PI) of the primary response 
to LCM virus in vivo; this mixture was then added to labeled target cells. The 
carrier cells did not compete significantly. These results thus suggested that the 
suppressive action of carrier cells depends upon their content of infectious virus 
or upon some other active process mediated only by living cells. 
In vivo, transfer of doses of 5 x 107 down to 5 x  1@ carrier cells to normal mice 
either up to 7 days before, or up to 3 days after routine infection with 250 PFU of 
WE3  LCM,  markedly suppressed the primary cytotoxic T-cell response mea- 
sured 7 days after infection, thus confirming  previous results of Zinkernagel and 
Doherty (21). This effect could be duplicated, however, by transferring a water- 
lysed and sonically disrupted preparation of 2.5 × 107 carrier cells or by a dose of MALCOM  B.  C.  DUNLOP  AND  ROBERT  V.  BLANDEN  1141 
2.5  x  104 PFU of WE3  LCM virus, the amount of virus present in 2.5  x  107 
carrier spleen cells. 
The results from all these in vitro and in vivo experiments therefore suggest a 
common mechanism of suppression of cytotoxic T-cell responses based upon a 
high level of virus (or living infected cells) being present in the environment of 
the responding T cells. They do not support the hypothesis that active T-cell 
suppression is responsible for tolerance in the cytotoxic T-cell population in 
LCM virus congenital carriers (1-5)  or other carrier states induced by large 
virus doses (5). 
What then could account for the observed suppression? Since LCM virus is not 
overtly cytopathic for lymphoid cells (4,  5),  direct killing of T  cells by virus 
seems an unlikely explanation. One possible mechanism is based upon findings 
that  one cytotoxic T  cell  can kill  another  (29-31), provided the  former has 
receptors complementary  for antigenic patterns on the latter (30). The presence 
of a high level of  virus in the environment of responding cytotoxic T cells specific 
for LCM virus-induced antigenic patterns could result in cytotoxic cells or their 
precursors, becoming infected and displaying antigenic patterns complementary 
for their own antigen receptors. This could then produce suicide of an individual 
cytotoxic  cell, for example, in the act of endocytosis  or mutual killing of adjacent 
cells, for example, infected, daughter, cytotexic T cells resulting from antigen- 
induced mitosis of a  precursor.  In essence,  this mechanism is  the  simplest 
implementation of the principle of CTorbidden clone deletion" as suggested by 
Burnet  (8), except that in the case of LCM virus infection it could occur in 
secondary lymphoid tissues during adult life as well as in the thymus, the site 
suggested for deletion of self-reactive clones of cytotoxic T cells during ontog- 
eny.  5 A direct test of the proposition is not strictly possible without methods for 
obtaining pure cytotoxic T-cell clones specific for LCM virus-induced antigen 
patterns on syngeneic cell surface membranes. However, we have presented 
here evidence that LCM virus-specific cytotoxic T cells can lyse infected T cells 
from a Con A-stimulated population (Table V). These data support the feasibil- 
ity of the clonal deletion model in LCM virus carriers outlined above. 
Summary 
The cytotoxic T-cell  response to lymphocytic choriomeningitis (LCM) virus 
infection was suppressed either in vitro or in vivo by addition of a high level of 
syngeneic virus-infected cells or syngeneic cells from congenital LCM  virus 
carriers to the environment of the responding cells.  This effect was not dupli- 
cated by formaldehyde-fixed  carrier cells, nor could it be accounted for by "cold" 
target competition by carrier cells at the level of the cytotoxicity assay. Con- 
versely, suppression was produced in vivo by water-lysed, ultrasonically treated 
carrier cell suspensions, or by a  large dose of LCM virus equivalent to that 
contained in the carrier cells. Thus a high level of infectious virus was a common 
factor in all observed examples of suppression. 
Based upon this, the following hypothesis, a  form of "forbidden clone dele- 
tion," was proposed to account for virus-specific cytotoxic T-cell tolerance in 
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LCM virus congenital carriers, or in high dose suppression. A high level of  virus 
in lymphoid tissues, while not cytopathic  per se, may result in infection of all or 
most T  cells; this then may lead to deletion either via "suicide" of individual, 
infected, cytotoxic T  cells with receptors specific for virus-induced antigenic 
patterns on their own surface membranes, or by mutual lysis of two adjacent T 
cells. 
We are very grateful to Professor  Gordon  Ada and Dr. Rod Langman for stimulating discussions. 
Received for publication 30 November 1976. 
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